Kreiskliniken Reutlingen gGmbH Klinikum am Steinenberg Reutlingen/Medizinische Klinik I

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy	Metastatic Gastro-esophageal Adenocarcinoma	Active, not recruiting	Phase 2	2026-01-07		NCT06680622

Clinical trials